Variant report

Variant	nsv515800
Chromosome Location	chr17:17322196-17344653
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:601)
CpG islands
(count:122)
Chromatin interactive
region (count:26)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:601 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:17336791-17336877	HepG2	liver:	n/a	n/a
2	ARID3A	chr17:17338615-17338970	HepG2	liver:	n/a	n/a
3	ARID3A	chr17:17343355-17343673	HepG2	liver:	n/a	n/a
4	ATF3	chr17:17338425-17338994	A549	lung:	n/a	n/a
5	BACH1	chr17:17343409-17344051	H1-hESC	embryonic stem cell:	n/a	n/a
6	BCL3	chr17:17343257-17343960	A549	lung:	n/a	n/a
7	BCL3	chr17:17338460-17339116	A549	lung:	n/a	n/a
8	BHLHE40	chr17:17338684-17338974	K562	blood:	n/a	n/a
9	BRCA1	chr17:17338669-17338908	Hela-S3	cervix:	n/a	n/a
10	CBX3	chr17:17327856-17328305	K562	blood:	n/a	n/a
11	CBX3	chr17:17327816-17328343	K562	blood:	n/a	n/a
12	CBX3	chr17:17343171-17343831	HCT-116	colon:	n/a	n/a
13	CBX3	chr17:17343275-17343681	K562	blood:	n/a	n/a
14	CBX3	chr17:17324967-17325222	K562	blood:	n/a	n/a
15	CEBPB	chr17:17337799-17338185	IMR90	lung:	n/a	chr17:17337987-17337998
16	CEBPB	chr17:17336538-17336923	IMR90	lung:	n/a	chr17:17336722-17336733
17	CEBPB	chr17:17337777-17338180	Hela-S3	cervix:	n/a	chr17:17337987-17337998
18	CEBPB	chr17:17336636-17336872	K562	blood:	n/a	chr17:17336722-17336733
19	CEBPB	chr17:17341254-17341571	Hela-S3	cervix:	n/a	chr17:17341399-17341410
20	CEBPB	chr17:17336572-17336917	K562	blood:	n/a	chr17:17336722-17336733
21	CEBPB	chr17:17343316-17343607	IMR90	lung:	n/a	n/a
22	CEBPB	chr17:17343390-17343531	HepG2	liver:	n/a	n/a
23	CEBPB	chr17:17336568-17336881	A549	lung:	n/a	chr17:17336722-17336733
24	CEBPB	chr17:17337874-17338059	HepG2	liver:	n/a	chr17:17337987-17337998
25	CEBPB	chr17:17341252-17341583	HepG2	liver:	n/a	chr17:17341399-17341410
26	CEBPB	chr17:17343294-17343609	K562	blood:	n/a	n/a
27	CEBPB	chr17:17343294-17343665	A549	lung:	n/a	n/a
28	CEBPB	chr17:17336645-17336843	HepG2	liver:	n/a	chr17:17336722-17336733
29	CEBPB	chr17:17337805-17338171	A549	lung:	n/a	chr17:17337987-17337998
30	CEBPB	chr17:17337800-17338180	HepG2	liver:	n/a	chr17:17337987-17337998
31	CEBPB	chr17:17343316-17343660	HepG2	liver:	n/a	n/a
32	CEBPB	chr17:17336539-17336927	HepG2	liver:	n/a	chr17:17336722-17336733
33	CEBPB	chr17:17337787-17338208	A549	lung:	n/a	chr17:17337987-17337998
34	CEBPB	chr17:17343316-17343661	HepG2	liver:	n/a	n/a
35	CEBPB	chr17:17343309-17343657	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr17:17343310-17343649	K562	blood:	n/a	n/a
37	CEBPB	chr17:17341280-17341541	K562	blood:	n/a	chr17:17341399-17341410
38	CEBPB	chr17:17336576-17336905	Hela-S3	cervix:	n/a	chr17:17336722-17336733
39	CEBPB	chr17:17336555-17336923	HepG2	liver:	n/a	chr17:17336722-17336733
40	CEBPB	chr17:17338473-17339394	IMR90	lung:	n/a	n/a
41	CEBPB	chr17:17336508-17336868	HepG2	liver:	n/a	chr17:17336722-17336733
42	CEBPB	chr17:17336657-17336878	H1-hESC	embryonic stem cell:	n/a	chr17:17336722-17336733
43	CEBPB	chr17:17338767-17338826	HepG2	liver:	n/a	n/a
44	CEBPB	chr17:17341249-17341587	A549	lung:	n/a	chr17:17341399-17341410
45	CEBPB	chr17:17343263-17343662	MCF-7	breast:	n/a	n/a
46	CEBPB	chr17:17341221-17341860	IMR90	lung:	n/a	chr17:17341399-17341410
47	CEBPB	chr17:17337855-17338133	H1-hESC	embryonic stem cell:	n/a	chr17:17337987-17337998
48	CEBPB	chr17:17337739-17338225	A549	lung:	n/a	chr17:17337987-17337998
49	CEBPB	chr17:17336657-17336909	ECC-1	luminal epithelium:	n/a	chr17:17336722-17336733
50	CEBPB	chr17:17337808-17338146	K562	blood:	n/a	chr17:17337987-17337998

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:17343875-17343925	SK-N-MC	brain:	n/a
2	chr17:17343875-17343925	GM12892	blood:	n/a
3	chr17:17338842-17338892	LNCaP	prostate:	n/a
4	chr17:17338842-17338892	K562	blood:	n/a
5	chr17:17338842-17338892	HEK293	kidney:	embryo
6	chr17:17343875-17343925	PrEC	prostate:	n/a
7	chr17:17343875-17343925	SAEC	small airway:	n/a
8	chr17:17338842-17338892	GM12892	blood:	n/a
9	chr17:17343875-17343925	IMR90	lung:	fetal
10	chr17:17343875-17343925	HRCEpiC	kidney:	n/a
11	chr17:17338842-17338892	AG09309	skin:	n/a
12	chr17:17343875-17343925	GM19239	blood:	n/a
13	chr17:17343875-17343925	SK-N-SH	brain:	n/a
14	chr17:17338842-17338892	T-47D	breast:	n/a
15	chr17:17343875-17343925	Hela-S3	cervix:	n/a
16	chr17:17338842-17338892	A549	lung:	n/a
17	chr17:17338842-17338892	HRE	kidney:	n/a
18	chr17:17338842-17338892	H1-hESC	embryonic stem cell:	embryo
19	chr17:17338842-17338892	ProgFib	skin:	n/a
20	chr17:17343875-17343925	Hepatocyte	liver:	n/a
21	chr17:17343875-17343925	ECC-1	luminal epithelium:	n/a
22	chr17:17338842-17338892	ovcar-3	ovarian:	n/a
23	chr17:17338842-17338892	HPAEpiC	pulmonary alveolar:	n/a
24	chr17:17338842-17338892	NB4	blood:	n/a
25	chr17:17338842-17338892	HMEC	breast:	n/a
26	chr17:17338842-17338892	AG04450	lung:	fetal
27	chr17:17338842-17338892	SK-N-SH	brain:	n/a
28	chr17:17343875-17343925	AoSMC	blood vessel:	n/a
29	chr17:17338842-17338892	SAEC	small airway:	n/a
30	chr17:17338842-17338892	BE2_C	brain:	n/a
31	chr17:17343875-17343925	HRE	kidney:	n/a
32	chr17:17343875-17343925	U87	brain:	n/a
33	chr17:17338842-17338892	HL-60	blood:	n/a
34	chr17:17338842-17338892	BJ	skin:	n/a
35	chr17:17343875-17343925	A549	lung:	n/a
36	chr17:17338842-17338892	NT2-D1	testis:	n/a
37	chr17:17343875-17343925	HCM	heart:	n/a
38	chr17:17338842-17338892	HUVEC	blood vessel:	n/a
39	chr17:17338842-17338892	HCPEpiC	choroid plexus:	n/a
40	chr17:17343875-17343925	HEEpiC	esophagus:	n/a
41	chr17:17338842-17338892	AG04449	skin:	fetal
42	chr17:17343875-17343925	HepG2	liver:	n/a
43	chr17:17343875-17343925	HAEpiC	amniotic membrane:	n/a
44	chr17:17338842-17338892	PrEC	prostate:	n/a
45	chr17:17338842-17338892	NHDF-neo	bronchial:	n/a
46	chr17:17343875-17343925	AG09309	skin:	n/a
47	chr17:17343875-17343925	MCF-7	breast:	n/a
48	chr17:17338842-17338892	HepG2	liver:	n/a
49	chr17:17338842-17338892	Caco-2	colon:	n/a
50	chr17:17338842-17338892	Hepatocyte	liver:	n/a

(count:26 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:17321962..17324766-chr17:17326555..17329436,3	K562	blood:
2	chr17:17323645..17325361-chr17:17339131..17341105,2	MCF-7	breast:
3	chr17:17261706..17263855-chr17:17343198..17345189,2	MCF-7	breast:
4	chr17:17336920..17339471-chr17:17342851..17344452,2	MCF-7	breast:
5	chr17:17335771..17338449-chr17:17342663..17345052,2	MCF-7	breast:
6	chr17:17291138..17292058-chr17:17343026..17343970,5	MCF-7	breast:
7	chr17:17342531..17346072-chr17:17347773..17351460,6	MCF-7	breast:
8	chr17:17336920..17339471-chr17:17342851..17344452,2	MCF-7	breast:
9	chr17:17344606..17346836-chr17:17348575..17350374,2	K562	blood:
10	chr17:17259250..17260032-chr17:17342972..17343523,2	MCF-7	breast:
11	chr17:17340093..17354118-chr17:17394085..17402192,31	MCF-7	breast:
12	chr17:17290703..17292981-chr17:17343527..17346178,2	MCF-7	breast:
13	chr17:17329242..17331427-chr17:17343296..17345855,2	MCF-7	breast:
14	chr17:17323645..17325361-chr17:17339131..17341105,2	MCF-7	breast:
15	chr17:17255909..17258113-chr17:17342308..17343826,2	MCF-7	breast:
16	chr17:17337262..17338945-chr17:17347016..17349151,2	MCF-7	breast:
17	chr17:17321962..17324766-chr17:17326555..17329436,3	K562	blood:
18	chr17:17258968..17259852-chr17:17343043..17343948,2	K562	blood:
19	chr17:17329242..17331427-chr17:17343296..17345855,2	MCF-7	breast:
20	chr17:17341170..17345071-chr17:17347034..17351413,6	MCF-7	breast:
21	chr17:17335195..17342131-chr17:17347291..17351486,7	MCF-7	breast:
22	chr17:17324473..17327302-chr17:17336395..17338556,2	MCF-7	breast:
23	chr17:17335771..17338449-chr17:17342663..17345052,2	MCF-7	breast:
24	chr17:17321553..17324468-chr17:17587073..17589435,2	MCF-7	breast:
25	chr17:17344282..17356772-chr17:17394630..17405312,31	MCF-7	breast:
26	chr17:17338847..17340811-chr17:17396652..17398902,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000227158	TF binding region
ENSG00000227158	CpG island
ENSG00000108551	chromatin interactions
ENSG00000227158	chromatin interactions

Extended variants
information (count: 962 )
Associated
traits (count: 162 )

Variant overlapped rSNPs/rCNVs (count:962 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs8079502	chr17:17322196-17322197	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs552101162	chr17:17322205-17322206	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs80350282	chr17:17322206-17322207	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs533798047	chr17:17322208-17322209	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs186147087	chr17:17322223-17322224	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs138123872	chr17:17322237-17322238	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs142703379	chr17:17322277-17322278	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs115171105	chr17:17322293-17322294	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs111330580	chr17:17322314-17322315	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs575827508	chr17:17322326-17322327	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs544760574	chr17:17322343-17322344	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs115213853	chr17:17322368-17322369	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs113113699	chr17:17322384-17322385	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs191304956	chr17:17322409-17322410	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs540646281	chr17:17322410-17322411	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs558280539	chr17:17322489-17322490	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs560265162	chr17:17322495-17322496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs141188315	chr17:17322501-17322502	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs543135329	chr17:17322509-17322510	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs370932695	chr17:17322548-17322549	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs79162701	chr17:17322556-17322557	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs563123912	chr17:17322562-17322563	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs531950421	chr17:17322655-17322656	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs551647813	chr17:17322668-17322669	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs571929729	chr17:17322677-17322678	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs527956054	chr17:17322678-17322679	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs183021196	chr17:17322682-17322683	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs541602428	chr17:17322729-17322730	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs535987345	chr17:17322741-17322742	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs555842050	chr17:17322750-17322751	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs538684288	chr17:17322752-17322753	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs538463725	chr17:17322769-17322770	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs187724732	chr17:17322848-17322849	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs12602640	chr17:17322930-17322931	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs35804604	chr17:17322973-17322974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs78033812	chr17:17322985-17322986	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs554178570	chr17:17323005-17323006	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs77816953	chr17:17323010-17323011	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs12603020	chr17:17323015-17323016	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs74659922	chr17:17323019-17323020	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs562984217	chr17:17323038-17323039	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs531810544	chr17:17323073-17323074	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs190949614	chr17:17323079-17323080	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs565320899	chr17:17323149-17323150	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs61172106	chr17:17323197-17323198	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs112936318	chr17:17323223-17323224	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs547767728	chr17:17323229-17323230	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs530981541	chr17:17323254-17323255	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs4539660	chr17:17323260-17323261	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs570574252	chr17:17323261-17323262	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:162)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22543975	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Cancer	17440070	CNVD

Chromatin state (count:341 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17308000-17322200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr17:17315400-17322800	Enhancers	Fetal Thymus	thymus
3	chr17:17317000-17327200	Enhancers	Fetal Muscle Leg	muscle
4	chr17:17317200-17324400	Enhancers	Left Ventricle	heart
5	chr17:17317600-17322200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr17:17318400-17322800	Weak transcription	Fetal Brain Male	brain
7	chr17:17318400-17324600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr17:17318800-17322600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
9	chr17:17318800-17324400	Enhancers	HepG2	liver
10	chr17:17319200-17322200	Enhancers	HSMMtube	muscle
11	chr17:17319200-17325000	Enhancers	K562	blood
12	chr17:17319400-17324600	Enhancers	Right Ventricle	heart
13	chr17:17319600-17324000	Enhancers	Brain Cingulate Gyrus	brain
14	chr17:17319600-17324400	Enhancers	Right Atrium	heart
15	chr17:17319800-17322800	Enhancers	Fetal Intestine Large	intestine
16	chr17:17319800-17322800	Enhancers	Fetal Intestine Small	intestine
17	chr17:17319800-17323600	Enhancers	Pancreas	Pancrea
18	chr17:17320000-17322400	Enhancers	HUVEC	blood vessel
19	chr17:17320200-17323800	Enhancers	Rectal Mucosa Donor 31	rectum
20	chr17:17320400-17323400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr17:17320600-17322200	Enhancers	Pancreatic Islets	Pancreatic Islet
22	chr17:17320600-17322600	Weak transcription	Skeletal Muscle Male	skeletal muscle
23	chr17:17320600-17323200	Weak transcription	Spleen	Spleen
24	chr17:17320600-17323400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr17:17320600-17323400	Weak transcription	Esophagus	oesophagus
26	chr17:17321000-17322200	Enhancers	Duodenum Mucosa	Duodenum
27	chr17:17321200-17324600	Enhancers	NHDF-Ad	bronchial
28	chr17:17321400-17322400	Enhancers	Osteobl	bone
29	chr17:17321400-17322600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr17:17321400-17323400	Enhancers	Skeletal Muscle Female	skeletal muscle
31	chr17:17321400-17323600	Enhancers	Brain Hippocampus Middle	brain
32	chr17:17321400-17324600	Enhancers	Muscle Satellite Cultured Cells	--
33	chr17:17321600-17323400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr17:17321600-17323400	Enhancers	Adipose Nuclei	Adipose
35	chr17:17321600-17323600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
36	chr17:17321600-17323800	Enhancers	Brain Substantia Nigra	brain
37	chr17:17321600-17325000	Enhancers	Placenta	Placenta
38	chr17:17321800-17322200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
39	chr17:17321800-17323600	Enhancers	Brain Angular Gyrus	brain
40	chr17:17321800-17323800	Enhancers	Breast Myoepithelial Primary Cells	Breast
41	chr17:17321800-17324000	Enhancers	Hela-S3	cervix
42	chr17:17321800-17324600	Enhancers	NHLF	lung
43	chr17:17322000-17322200	Enhancers	Primary hematopoietic stem cells	blood
44	chr17:17322000-17322200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr17:17322000-17322200	Enhancers	Small Intestine	intestine
46	chr17:17322000-17322600	Enhancers	Thymus	Thymus
47	chr17:17322000-17322800	Enhancers	Gastric	stomach
48	chr17:17322000-17322800	Enhancers	HMEC	breast
49	chr17:17322000-17323400	Weak transcription	HSMM	muscle
50	chr17:17322000-17323800	Enhancers	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links